查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539393

生物可吸收血管支架市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031

Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球生物可吸收血管支架市场的综合报告。本报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 生物可吸收血管支架市场规模（2024年）：3.39亿美元
  • 预测市场规模（2031年）：5.928亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：8.3%

生物可吸收血管支架市场 - 研究范围

生物可吸收血管支架是用于治疗冠状动脉疾病的创新医疗器材。这些支架目的是为血管提供临时结构支撑，并随着时间的推移逐渐溶解，无需永久性植入物。该市场面向医院、心臟中心和专科诊所，提供各种类型的支架，包括聚合物支架、金属支架和混合支架。市场成长的驱动力是心血管疾病的日益普及、支架材料和设计的进步以及对微创手术的需求不断成长。

推动市场成长的因素：

全球生物可吸收血管支架市场是由几个关键因素推动的，包括心血管疾病的日益流行，以及对支持血管癒合的有效和临时解决方案的需求。新型生物材料的开发和支架设计的改进等技术进步改善治疗结果和病人安全。对微创手术的日益青睐也推动了对生物可吸收血管支架的需求。此外，增加研发投资以及目的是改善心血管治疗的积极政府措施进一步推动了市场成长。

市场限制因素：

儘管成长前景广阔，但生物可吸收血管支架市场面临成本高且偿付范围有限的挑战。生物可吸收血管支架所需的复杂製造流程和先进材料导致成本上升，并可能成为市场引进的障碍，特别是在新兴国家。此外，市场还面临与支架的长期性能和生物相容性相关的监管障碍和安全问题。应对这些挑战需要持续创新、成本管理策略以及与医疗保健提供者和政策制定者的合作。

市场机会

由于技术创新和不断扩大的应用，生物可吸收血管支架市场提供了巨大的成长机会。支架材料新兴市场的发展，包括新型聚合物和生物活性涂料的开发，开闢新的市场扩张途径。在周边血管介入治疗中日益采用生物可吸收血管支架，以及远端监测和个人化治疗计划等数位健康技术的整合改善患者的治疗效果并扩大市场范围。策略合作伙伴关係、研发投资以及采用具有成本效益的解决方案对于利用这些机会并推动永续市场成长非常重要。

本报告解决的关键问题

  • 推动生物可吸收血管支架市场全球成长的关键因素是什么？
  • 哪些支架类型和应用推动生物可吸收血管支架在各种医疗保健环境中的采用？
  • 由于技术进步，生物可吸收血管支架市场的竞争格局发生了什么样的变化？
  • 谁是生物可吸收血管支架市场的主要参与者？
  • 全球生物可吸收血管支架市场的新趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 世界产业展望
    • 全球 GDP 成长前景
    • 全球医疗保健支出前景
  • 新冠肺炎（COVID-19）影响分析
  • 预测因子 - 相关性和影响

第3章 增值见解

  • 产品采用率分析
  • 疾病流行病学
  • 技术评估
  • 监理状况
  • 供应链分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 价格分析，2024年

  • 主要亮点
  • 影响产品价格的主要因素
  • 价格分析：依产品分类
  • 区域定价与产品偏好

第5章 全球生物可吸收血管支架市场展望：实绩（2019-2023）与预测（2024-2031）

  • 主要亮点
    • 市场数量（单位）预测
    • 市场规模（十亿美元）和年成长率
    • 绝对数量的机会
  • 市场规模分析与预测（十亿美元）
    • 过去的市场规模（十亿美元）分析，2019-2023年
    • 2024-2031年目前市场规模（十亿美元）分析与预测
  • 全球生物可吸收血管支架市场展望：产品
    • 简介/主要发现
    • 过去的市场规模（十亿美元）分析，依产品，2019-2023年
    • 2024-2031年当前市场规模（十亿美元）和数量（单位）分析和预测，依产品
  • 市场吸引力分析：产品
  • 全球生物可吸收血管支架市场展望：应用
    • 简介/主要发现
    • 2019-2023年过去的市场规模（十亿美元）分析，依应用
    • 2024-2031年当前市场规模（十亿美元）的分析与预测，依应用
  • 市场吸引力分析：应用
  • 全球生物可吸收血管支架市场展望：最终用户
    • 简介/主要发现
    • 2019-2023年历史市场规模（十亿美元）分析，依最终用户
    • 2024-2031年目前市场规模（十亿美元）的分析与预测，依最终用户
  • 市场吸引力分析：最终用户

第6章 全球生物可吸收血管支架市场展望：地区

  • 主要亮点
  • 2019-2023年历史市场规模（十亿美元）分析，依地区
  • 2024-2031年当前市场规模（十亿美元）分析和预测：依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第7章 北美生物可吸收血管支架市场展望：实绩（2019-2023）与预测（2024-2031）

第8章 欧洲生物可吸收血管支架市场前景：实绩（2019-2023年）与预测（2024-2031年）

第9章 东亚生物可吸收血管支架市场展望：实绩（2019-2023）与预测（2024-2031）

第10章 南亚和大洋洲生物可吸收血管支架市场前景：实绩（2019-2023年）和预测（2024-2031年）

第11章 拉丁美洲生物可吸收血管支架市场展望：实绩（2019-2023）与预测（2024-2031）

第12章 中东和非洲生物可吸收血管支架市场展望：实绩（2019-2023）和预测（2024-2031）

第13章 竞争态势

  • 2024年市占率分析
  • 市场结构
    • 竞争强度图：依市场划分
    • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Meril Life Sciences Pvt. Ltd.
    • Zeus Company LLC
    • Biotronik
    • Abbott
    • MicroPort Scientific Corporation
    • Kyoto Medical
    • Elixir Medical（MedImpact Healthcare Systems, Inc.）
    • Cigna
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • REVA Medical

第14章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34715

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Bioresorbable Vascular Scaffold Market Size (2024E): US$339.0 Mn
  • Projected Market Value (2031F):US$592.8 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031):8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds are innovative medical devices used in the treatment of coronary artery disease. These scaffolds are designed to provide temporary structural support to blood vessels and gradually dissolve over time, eliminating the need for permanent implants. The market caters to hospitals, cardiac centers, and specialized clinics, offering a range of scaffold types including polymer-based, metal-based, and hybrid scaffolds. Market growth is driven by increasing prevalence of cardiovascular diseases, advancements in scaffold materials and design, and rising demand for minimally invasive procedures.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the growing incidence of cardiovascular diseases and the need for effective and temporary solutions to support vessel healing. Technological advancements, such as the development of new biomaterials and improved scaffold designs, are enhancing treatment outcomes and patient safety. The rising preference for minimally invasive procedures is also driving demand for bioresorbable scaffolds. Additionally, increasing investments in research and development and favorable government initiatives aimed at improving cardiovascular care are further fueling market growth.

Market Restraints:

Despite promising growth prospects, the bioresorbable vascular scaffold market faces challenges related to high cost and limited reimbursement coverage. The complex manufacturing process and the advanced materials required for bioresorbable scaffolds contribute to higher costs, which can be a barrier to market adoption, especially in emerging economies. Moreover, the market encounters regulatory hurdles and safety concerns associated with long-term performance and biocompatibility of scaffolds. Addressing these challenges requires ongoing innovation, cost management strategies, and collaboration with healthcare providers and policymakers.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant growth opportunities driven by technological innovations and expanding applications. Advances in scaffold materials, such as the development of novel polymers and bioactive coatings, are opening new avenues for market expansion. The increasing adoption of bioresorbable scaffolds in peripheral vascular interventions and the integration of digital health technologies, such as remote monitoring and personalized treatment plans, are enhancing patient outcomes and broadening market scope. Strategic partnerships, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and drive sustained market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
  • Which scaffold types and applications are driving bioresorbable scaffold adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the bioresorbable vascular scaffold market?
  • Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global bioresorbable vascular scaffold market?

Competitive Intelligence and Business Strategy:

Leading players in the global bioresorbable vascular scaffold market, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced scaffolds with improved biocompatibility, strength, and degradation profiles. Collaborations with research institutions, healthcare providers, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving bioresorbable vascular scaffold landscape.

Key Companies Profiled:

  • Meril Life Sciences Pvt. Ltd.
  • Zeus Company LLC
  • Biotronik
  • Abbott
  • MicroPort Scientific Corporation
  • Kyoto Medical
  • Elixir Medical (MedImpact Healthcare Systems, Inc.)
  • Cigna
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • REVA Medical

Bioresorbable Vascular Scaffold Market Segmentation

By Product

  • Metal Bioresorbable Vascular Scaffold
  • Polymer Bioresorbable Vascular Scaffold

By Application

  • Peripheral Artery
  • Coronary Artery

By End User

  • Hospitals
  • Ambulatory Care Centers
  • Cardiac Centers

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Technology Assessment
  • 3.4. Regulatory Landscape
  • 3.5. Supply Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Price Analysis, 2024

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
  • 5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
      • 5.3.3.1. Metal Bioresorbable Vascular Scaffold
      • 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Bioresorbable Vascular Scaffold Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
      • 5.5.3.1. Peripheral Artery
      • 5.5.3.2. Coronary Artery
  • 5.6. Market Attractiveness Analysis: Application
  • 5.7. Global Bioresorbable Vascular Scaffold Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
      • 5.7.3.1. Hospitals
      • 5.7.3.2. Ambulatory Care Centers
      • 5.7.3.3. Cardiac Centers
      • 5.7.3.4. Others
  • 5.8. Market Attractiveness Analysis: End User

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 7.4.1. Metal Bioresorbable Vascular Scaffold
    • 7.4.2. Polymer Bioresorbable Vascular Scaffold
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 7.5.1. Peripheral Artery
    • 7.5.2. Coronary Artery
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Care Centers
    • 7.6.3. Cardiac Centers
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 8.4.1. Metal Bioresorbable Vascular Scaffold
    • 8.4.2. Polymer Bioresorbable Vascular Scaffold
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 8.5.1. Peripheral Artery
    • 8.5.2. Coronary Artery
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Care Centers
    • 8.6.3. Cardiac Centers
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 9.4.1. Metal Bioresorbable Vascular Scaffold
    • 9.4.2. Polymer Bioresorbable Vascular Scaffold
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 9.5.1. Peripheral Artery
    • 9.5.2. Coronary Artery
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Care Centers
    • 9.6.3. Cardiac Centers
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 10.4.1. Metal Bioresorbable Vascular Scaffold
    • 10.4.2. Polymer Bioresorbable Vascular Scaffold
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 10.5.1. Peripheral Artery
    • 10.5.2. Coronary Artery
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Care Centers
    • 10.6.3. Cardiac Centers
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 11.4.1. Metal Bioresorbable Vascular Scaffold
    • 11.4.2. Polymer Bioresorbable Vascular Scaffold
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 11.5.1. Peripheral Artery
    • 11.5.2. Coronary Artery
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Care Centers
    • 11.6.3. Cardiac Centers
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 12.4.1. Metal Bioresorbable Vascular Scaffold
    • 12.4.2. Polymer Bioresorbable Vascular Scaffold
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 12.5.1. Peripheral Artery
    • 12.5.2. Coronary Artery
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Care Centers
    • 12.6.3. Cardiac Centers
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meril Life Sciences Pvt. Ltd.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Zeus Company LLC
    • 13.3.3. Biotronik
    • 13.3.4. Abbott
    • 13.3.5. MicroPort Scientific Corporation
    • 13.3.6. Kyoto Medical
    • 13.3.7. Elixir Medical (MedImpact Healthcare Systems, Inc.)
    • 13.3.8. Cigna
    • 13.3.9. B. Braun Melsungen AG
    • 13.3.10. Boston Scientific Corporation
    • 13.3.11. REVA Medical

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations